Mariel Arvizu1, Lidia Minguez-Alarcon2,3, Siwen Wang1, Makiko Mitsunami1, Jennifer J Stuart4,5, Janet W Rich-Edwards3,4,5, Bernard Rosner6, Jorge E Chavarro1,3,4. 1. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. 2. Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA. 3. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. 4. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. 5. Division of Women's Health, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. 6. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Abstract
BACKGROUND: Many studies have linked intakes of fat and of specific fatty acids during pregnancy with preeclampsia; however, information on the association of intake before pregnancy with hypertensive disorders of pregnancy (HDP) is scant. OBJECTIVES: We evaluated the associations of intakes of major and specific types of fat before pregnancy with the risks of HDP, including preeclampsia and gestational hypertension (GHTN). METHODS: We followed 11,535 women without chronic disease participating in the Nurses' Health Study II from 1991 and 2009. Pre-pregnancy dietary fat was assessed by an FFQ. Intakes of total fat, saturated fat, trans fatty acid (TFA), MUFAs, PUFAs, and fat subtypes (omega-3 and omega-6) were categorized into quintiles of intake. HDP were self-reported. The RRs (95% CIs) of HDP were estimated by log-binomial generalized estimating equation regression models, with an exchangeable correlation matrix to account for repeated pregnancies while adjusting for potential confounders. RESULTS: During 19 years of follow-up, there were 495 cases of preeclampsia (2.9%) and 561 (3.3%) cases of GHTN in 16,892 singleton pregnancies. The mean age at pregnancy was 34.6 years (SD, 3.9 years). Among major fat types, only pre-pregnancy TFA was related to a higher risk of HDP (RR, 1.32; 95% CI: 1.05-1.66), and only for preeclampsia (RR, 1.50; 95% CI: 1.07-2.10) but not for GHTN (RR, 1.21; 95% CI: 0.87-1.70). Among specific types of PUFAs, intake of arachidonic acid was positively related with GHTN (RR, 1.43; 95% CI: 1.00-2.04) but not preeclampsia (RR, 1.08; 95% CI: 0.75-1.57). In analyses restricted to pregnancies 1 year after the diet assessment, women with the highest intake of long-chain omega-3 fatty acids had a 31% lower risk of HDP (95% CI: 3%-51%), which was driven by preeclampsia (RR, 0.55; 95% CI: 0.33-0.92). CONCLUSIONS: Pre-pregnancy intakes of total fat, saturated fat, and MUFA were unrelated to HDP, whereas TFA was positively related to HDP. These findings highlight the importance of ongoing efforts to eliminate TFA from the global food supply.
BACKGROUND: Many studies have linked intakes of fat and of specific fatty acids during pregnancy with preeclampsia; however, information on the association of intake before pregnancy with hypertensive disorders of pregnancy (HDP) is scant. OBJECTIVES: We evaluated the associations of intakes of major and specific types of fat before pregnancy with the risks of HDP, including preeclampsia and gestational hypertension (GHTN). METHODS: We followed 11,535 women without chronic disease participating in the Nurses' Health Study II from 1991 and 2009. Pre-pregnancy dietary fat was assessed by an FFQ. Intakes of total fat, saturated fat, trans fatty acid (TFA), MUFAs, PUFAs, and fat subtypes (omega-3 and omega-6) were categorized into quintiles of intake. HDP were self-reported. The RRs (95% CIs) of HDP were estimated by log-binomial generalized estimating equation regression models, with an exchangeable correlation matrix to account for repeated pregnancies while adjusting for potential confounders. RESULTS: During 19 years of follow-up, there were 495 cases of preeclampsia (2.9%) and 561 (3.3%) cases of GHTN in 16,892 singleton pregnancies. The mean age at pregnancy was 34.6 years (SD, 3.9 years). Among major fat types, only pre-pregnancy TFA was related to a higher risk of HDP (RR, 1.32; 95% CI: 1.05-1.66), and only for preeclampsia (RR, 1.50; 95% CI: 1.07-2.10) but not for GHTN (RR, 1.21; 95% CI: 0.87-1.70). Among specific types of PUFAs, intake of arachidonic acid was positively related with GHTN (RR, 1.43; 95% CI: 1.00-2.04) but not preeclampsia (RR, 1.08; 95% CI: 0.75-1.57). In analyses restricted to pregnancies 1 year after the diet assessment, women with the highest intake of long-chain omega-3 fatty acids had a 31% lower risk of HDP (95% CI: 3%-51%), which was driven by preeclampsia (RR, 0.55; 95% CI: 0.33-0.92). CONCLUSIONS: Pre-pregnancy intakes of total fat, saturated fat, and MUFA were unrelated to HDP, whereas TFA was positively related to HDP. These findings highlight the importance of ongoing efforts to eliminate TFA from the global food supply.
Authors: Ying Bao; Monica L Bertoia; Elizabeth B Lenart; Meir J Stampfer; Walter C Willett; Frank E Speizer; Jorge E Chavarro Journal: Am J Public Health Date: 2016-07-26 Impact factor: 9.308
Authors: Jorge E Chavarro; Lidia Mínguez-Alarcón; Jaime Mendiola; Ana Cutillas-Tolín; José J López-Espín; Alberto M Torres-Cantero Journal: Hum Reprod Date: 2014-01-12 Impact factor: 6.918
Authors: Jennifer J Stuart; Lauren J Tanz; Stacey A Missmer; Eric B Rimm; Donna Spiegelman; Tamarra M James-Todd; Janet W Rich-Edwards Journal: Ann Intern Med Date: 2018-07-03 Impact factor: 25.391
Authors: A S Olafsdottir; G V Skuladottir; I Thorsdottir; A Hauksson; H Thorgeirsdottir; L Steingrimsdottir Journal: BJOG Date: 2006-03 Impact factor: 6.531
Authors: Emily Oken; Yi Ning; Sheryl L Rifas-Shiman; Janet W Rich-Edwards; Sjurdur F Olsen; Matthew W Gillman Journal: Ann Epidemiol Date: 2007-05-23 Impact factor: 3.797
Authors: Miriam F van Oostwaard; Josje Langenveld; Ewoud Schuit; Dimitri N M Papatsonis; Mark A Brown; Romano N Byaruhanga; Sohinee Bhattacharya; Doris M Campbell; Lucy C Chappell; Francesca Chiaffarino; Isabella Crippa; Fabio Facchinetti; Sergio Ferrazzani; Enrico Ferrazzi; Ernesto A Figueiró-Filho; Ingrid P M Gaugler-Senden; Camilla Haavaldsen; Jacob A Lykke; Alfred K Mbah; Vanessa M Oliveira; Lucilla Poston; Christopher W G Redman; Raed Salim; Baskaran Thilaganathan; Patrizia Vergani; Jun Zhang; Eric A P Steegers; Ben Willem J Mol; Wessel Ganzevoort Journal: Am J Obstet Gynecol Date: 2015-01-09 Impact factor: 8.661
Authors: Christine L Roberts; Jane B Ford; Charles S Algert; Sussie Antonsen; James Chalmers; Sven Cnattingius; Manjusha Gokhale; Milton Kotelchuck; Kari K Melve; Amanda Langridge; Carole Morris; Jonathan M Morris; Natasha Nassar; Jane E Norman; John Norrie; Henrik Toft Sørensen; Robin Walker; Christopher J Weir Journal: BMJ Open Date: 2011-05-24 Impact factor: 2.692
Authors: Wai-Yee Lim; Mary Chong; Philip C Calder; Kenneth Kwek; Yap-Seng Chong; Peter D Gluckman; Keith M Godfrey; Seang-Mei Saw; An Pan Journal: Medicine (Baltimore) Date: 2015-03 Impact factor: 1.889